Lack of tuberculosis trials in children unacceptable

August 19, 2008

Ensuring the involvement of children in the evaluation of tuberculosis treatment is critical as we move forward in developing effective responses to active and drug-susceptible tuberculosis (TB), argues a new essay in this week's PLoS Medicine.

William Burman (from the Denver Public Health and the University of Colorado Health Sciences Center, Denver, USA) and colleagues say that children are an often ignored but important part of tuberculosis control efforts. In high-burden settings, children make up as much as 20% of new cases of active tuberculosis. Young children are also at high risk of having severe, rapidly-progressive forms of tuberculosis.

But nearly 40 years after the development of short-course treatments in adults, there are still major uncertainties about dosing for children of common TB drugs. "Only in recent years has there been a substantial effort to manufacture child-friendly formulations of first-line tuberculosis drugs (such as crushable mini-pills, granules, oral suspensions)," say the authors. "And in the past 15 years, children have been included in only one study of new agents for tuberculosis: a large Phase 3 trial evaluating once-weekly rifapentine + isoniazid for treatment of latent tuberculosis."

Including children in drug development is especially critical, say the authors, as the two main threats to tuberculosis control—HIV-related immunodeficiency and drug-resistant tuberculosis—challenge our ability to develop effective drug regimens.

Burman and colleagues outline several traditional barriers to the involvement of children in tuberculosis drug development such as difficulty confirming TB diagnosis, concern about side effects, and regulatory requirements. But they also describe how these barriers can be overcome, arguing that researchers, regulatory agencies, advocates, and government agencies and private foundations that fund drug development must insist that the development pathways for all new treatments include specific plans for when and how children will be involved.

"Children have the same right to benefit from research as do adults," say the authors. "While this lack of involvement may be understandable in the short-term, it is not acceptable in the long-term."

Citation: Burman WJ, Cotton MF, Gibb DM, Walker AS, Vernon AA, et al. (2008) Assuring the involvement of children in the evaluation of new tuberculosis treatment regimens. PLoS Med 5(8): e176. doi:10.1371/journal.pmed.0050176 medicine.plosjournals.org/perlserv/?request=get-document&doi:10.1371/journal.pmed.0050176>

Source: Public Library of Science

Explore further: One-third of world's people still have no proper toilets

Related Stories

Reenergizing antibiotics in the war against infections

June 24, 2015

Antibiotics are the mainstay in the treatment of bacterial infections, and together with vaccines, have enabled the near eradication of infectious diseases like tuberculosis, at least in developed countries. However, the ...

Ear-check via phone can ease path to diagnosis

December 18, 2014

Ear infections are common in babies and young children. That it is a frequent reason for young children's visit to doctors comes as no consolation for the parents of babies tugging at their ears and crying as the parents ...

Recommended for you

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

Quantum Theory May Explain Wishful Thinking

April 14, 2009

(PhysOrg.com) -- Humans don’t always make the most rational decisions. As studies have shown, even when logic and reasoning point in one direction, sometimes we chose the opposite route, motivated by personal bias or simply ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.